Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology
Giuseppe Andò,Francesco Pelliccia,Francesco Saia,Giuseppe Tarantini,Chiara Fraccaro,Fabrizio D'Ascenzo,Marco Zimarino,Mario Di Marino,Giampaolo Niccoli,Italo Porto,Paolo Calabrò,Felice Gragnano,Salvatore De Rosa,Raffaele Piccolo,Elisabetta Moscarella,Enrico Fabris,Rocco Antonio Montone,Carmen Spaccarotella,Ciro Indolfi,Gianfranco Sinagra,Pasquale Perrone Filardi,Working Group of Interventional Cardiology of the Italian Society of Cardiology
DOI: https://doi.org/10.1016/j.ijcard.2023.131694
2024-04-01
Abstract:Pulmonary embolism (PE) is a potentially life-threatening condition that remains a major global health concern. Noteworthy, patients with high- and intermediate-high-risk PE pose unique challenges because they often display clinical and hemodynamic instability, thus requiring rapid intervention to mitigate the risk of clinical deterioration and death. Importantly, recovery from PE is associated with long-term complications such as recurrences, bleeding with oral anticoagulant treatment, pulmonary hypertension, and psychological distress. Several novel strategies to improve risk factor characterization and management of patients with PE have recently been introduced. Accordingly, this position paper of the Working Group of Interventional Cardiology of the Italian Society of Cardiology deals with the landscape of high- and intermediate-high risk PE, with a focus on bridging the gap between the evolving standards of care and the current clinical practice. Specifically, the growing importance of catheter-directed therapies as part of the therapeutic armamentarium is highlighted. These interventions have been shown to be effective strategies in unstable patients since they offer, as compared with thrombolysis, faster and more effective restoration of hemodynamic stability with a consistent reduction in the risk of bleeding. Evolving standards of care underscore the need for continuous re-assessment of patient risk stratification. To this end, a multidisciplinary approach is paramount in refining selection criteria to deliver the most effective treatment to patients with unstable hemodynamics. In conclusion, the current management of unstable patients with PE should prioritize tailored treatment in a patient-oriented approach in which transcatheter therapies play a central role.